Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Finkel

Showing results (191-200 of 289) with videos related to

Pageof 29
Sort By:
Journal of Child Neurology|September 24, 2011
Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and IIIAllan M Glanzman, Jessica M O'Hagen, Michael P McDermott, et al.
Neuromuscular Disorders : NMD|July 31, 2007
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patientsJessica M O'Hagen, Allan M Glanzman, Michael P McDermott, et al.
Annals of Clinical and Translational Neurology|May 30, 2019
Neurofilament as a potential biomarker for spinal muscular atrophyBasil T Darras, Thomas O Crawford, Richard S Finkel, et al.
Journal of Neuromuscular Diseases|April 25, 2022
Step Activity Monitoring in Boys with Duchenne Muscular Dystrophy and its Correlation with Magnetic Resonance Measures and Functional PerformanceKavya S Nair, Donovan J Lott, Sean C Forbes, et al.
Journal of Pediatric Rehabilitation Medicine|July 19, 2021
Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophyMaria Fragala-Pinkham, Amy Pasternak, Michael P McDermott, et al.
Neurology|June 28, 2023
Association of Body Mass Index With Disease Progression in Children With Charcot-Marie-Tooth DiseaseGabrielle A Donlevy, Kayla M D Cornett, Sarah P Garnett, et al.
Neuromuscular Disorders : NMD|March 8, 2021
Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trialRichard S Finkel, Erika Finanger, Krista Vandenborne, et al.
International Psychogeriatrics|August 10, 2001
The Alzheimer's disease activities of daily living international scale (ADL-IS)B Reisberg, S Finkel, J Overall, et al.
Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association|November 18, 2011
Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND)Allan M Glanzman, Michael P McDermott, Jacqueline Montes, et al.
Radiology|May 23, 2013
Skeletal muscles of ambulant children with Duchenne muscular dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopySean C Forbes, Glenn A Walter, William D Rooney, et al.
Pageof 29

Showing results (191-200 of 289) with videos related to

Sort By:
Pageof 29
Journal of Child Neurology|September 24, 2011
Validation of the Expanded Hammersmith Functional Motor Scale in spinal muscular atrophy type II and IIIAllan M Glanzman, Jessica M O'Hagen, Michael P McDermott, et al.
Neuromuscular Disorders : NMD|July 31, 2007
An expanded version of the Hammersmith Functional Motor Scale for SMA II and III patientsJessica M O'Hagen, Allan M Glanzman, Michael P McDermott, et al.
Annals of Clinical and Translational Neurology|May 30, 2019
Neurofilament as a potential biomarker for spinal muscular atrophyBasil T Darras, Thomas O Crawford, Richard S Finkel, et al.
Journal of Neuromuscular Diseases|April 25, 2022
Step Activity Monitoring in Boys with Duchenne Muscular Dystrophy and its Correlation with Magnetic Resonance Measures and Functional PerformanceKavya S Nair, Donovan J Lott, Sean C Forbes, et al.
Journal of Pediatric Rehabilitation Medicine|July 19, 2021
Psychometric properties of the PEDI-CAT for children and youth with spinal muscular atrophyMaria Fragala-Pinkham, Amy Pasternak, Michael P McDermott, et al.
Neurology|June 28, 2023
Association of Body Mass Index With Disease Progression in Children With Charcot-Marie-Tooth DiseaseGabrielle A Donlevy, Kayla M D Cornett, Sarah P Garnett, et al.
Neuromuscular Disorders : NMD|March 8, 2021
Disease-modifying effects of edasalonexent, an NF-κB inhibitor, in young boys with Duchenne muscular dystrophy: Results of the MoveDMD phase 2 and open label extension trialRichard S Finkel, Erika Finanger, Krista Vandenborne, et al.
International Psychogeriatrics|August 10, 2001
The Alzheimer's disease activities of daily living international scale (ADL-IS)B Reisberg, S Finkel, J Overall, et al.
Pediatric Physical Therapy : the Official Publication of the Section on Pediatrics of the American Physical Therapy Association|November 18, 2011
Validation of the Children's Hospital of Philadelphia Infant Test of Neuromuscular Disorders (CHOP INTEND)Allan M Glanzman, Michael P McDermott, Jacqueline Montes, et al.
Radiology|May 23, 2013
Skeletal muscles of ambulant children with Duchenne muscular dystrophy: validation of multicenter study of evaluation with MR imaging and MR spectroscopySean C Forbes, Glenn A Walter, William D Rooney, et al.
Pageof 29